NVR Operating Cash Flow decreased by 22.8% to $339.69M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 63.5%, from $207.78M to $339.69M. Over 4 years (FY 2021 to FY 2025), Operating Cash Flow shows relatively stable performance with a -2.5% CAGR. This decline may warrant attention — for this metric, higher values are generally preferred.
An increase indicates strong operational efficiency and cash generation, while a decrease may signal operational challenges or issues with working capital management.
This metric represents the total cash generated or consumed by a company's core business operations during a specific pe...
Standard across all industries; peers in the medical device and diagnostics sector typically maintain high conversion ratios of net income to operating cash flow.
net_cash_from_operating| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $192.76M | $461.27M | $260.10M | $309.33M | $137.88M | $605.70M | $817.20M | $315.52M | $28.68M | $658.08M | $495.71M | $146.46M | $232.69M | $358.26M | $637.05M | $207.78M | $35.11M | $438.71M | $439.73M | $339.69M |
| QoQ Change | — | +139.3% | -43.6% | +18.9% | -55.4% | +339.3% | +34.9% | -61.4% | -90.9% | >999% | -24.7% | -70.5% | +58.9% | +54.0% | +77.8% | -67.4% | -83.1% | >999% | +0.2% | -22.8% |
| YoY Change | — | — | — | — | -28.5% | +31.3% | +214.2% | +2.0% | -79.2% | +8.6% | -39.3% | -53.6% | +711.3% | -45.6% | +28.5% | +41.9% | -84.9% | +22.5% | -31.0% | +63.5% |